Free Trial
George Farmer

George Farmer Analyst Performance

Biotechnology Analyst at Scotiabank

George Farmer is a stock analyst at Scotiabank in the medical sector, covering 18 publicly traded companies. Over the past year, George Farmer has issued 17 stock ratings, including buy, hold, and sell recommendations. While full access to George Farmer's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights George Farmer's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
26 Last 5 Years
Buy Recommendations
76.00% 19 Buy Ratings
Companies Covered
18 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy76.0%19 ratings
Hold20.0%5 ratings
Sell4.0%1 ratings

Out of 25 total stock ratings issued by George Farmer at Scotiabank, the majority (76.0%) have been Buy recommendations, followed by 20.0% Hold and 4.0% Sell.

Exchange Coverage

ExchangePercentageCount
NASDAQ
100.0% of companies on NASDAQ
18 companies

George Farmer, an analyst at Scotiabank, currently covers 18 companies listed on , with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Medical
18 companies
100.0%

George Farmer of Scotiabank specializes in stock coverage within the Medical sector.

Coverage Industries

IndustryPercentage
MED - BIOMED/GENE
13 companies
72.2%
MED - DRUGS
3 companies
16.7%
PHARMACEUTICAL PREPARATIONS
1 company
5.6%
BIOTECHNOLOGY
1 company
5.6%

George Farmer's Ratings History at Scotiabank

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Biomea Fusion, Inc. stock logo
BMEA
Biomea Fusion
8/6/2025Lower Price Target$1.53$10.00Sector Outperform
Arcellx, Inc. stock logo
ACLX
Arcellx
7/31/2025Boost Price Target$71.25$133.00Sector Outperform
Sage Therapeutics, Inc. stock logo
SAGE
Sage Therapeutics
7/8/2025Downgrade$9.17$9.20Hold
INmune Bio, Inc. stock logo
INMB
INmune Bio
7/1/2025Reiterated Rating$2.31Sector Underperform
Arcellx, Inc. stock logo
ACLX
Arcellx
5/9/2025Lower Price Target$56.04$93.00Sector Outperform
Syndax Pharmaceuticals, Inc. stock logo
SNDX
Syndax Pharmaceuticals
5/6/2025Boost Price Target$11.35$17.00Sector Perform
Protara Therapeutics, Inc. stock logo
TARA
Protara Therapeutics
4/16/2025Initiated Coverage$4.17$12.00Sector Outperform
Tempest Therapeutics, Inc. stock logo
TPST
Tempest Therapeutics
4/10/2025Reiterated Rating$7.15$9.00Sector Perform
Tempest Therapeutics, Inc. stock logo
TPST
Tempest Therapeutics
3/28/2025Lower Price Target$10.37$91.00Sector Outperform
Adaptimmune Therapeutics PLC stock logo
ADAP
Adaptimmune Therapeutics
3/21/2025Lower Price Target$0.28$1.40Sector Outperform
Janux Therapeutics, Inc. stock logo
JANX
Janux Therapeutics
2/28/2025Lower Price Target$32.89$41.00Sector Perform
NewAmsterdam Pharma Company N.V. stock logo
NAMS
NewAmsterdam Pharma
2/27/2025Boost Price Target$20.98$52.00Sector Outperform
BioMarin Pharmaceutical Inc. stock logo
BMRN
BioMarin Pharmaceutical
2/20/2025Boost Price Target$68.80$80.00Sector Perform
Viking Therapeutics, Inc. stock logo
VKTX
Viking Therapeutics
2/13/2025Initiated Coverage$29.32$102.00Sector Outperform
Biogen Inc. stock logo
BIIB
Biogen
2/13/2025Lower Price Target$138.53$224.00Sector Outperform
Sage Therapeutics, Inc. stock logo
SAGE
Sage Therapeutics
2/12/2025Lower Price Target$7.22$12.00Sector Outperform
Aura Biosciences, Inc. stock logo
AURA
Aura Biosciences
10/18/2024Boost Price Target$11.75$23.00Sector Outperform